Investigational Site Number 752101

Stockholm 14186

0 studies enrolling now · 2 studies all time

What they study most

Dyslipidemia, Type 1 Diabetes Mellitus

Studies at this site

• Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia) — Completed
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus — Completed